Baxter ROA 2006-2018 | BAX

Current and historical return on assets (ROA) values for Baxter (BAX) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Baxter ROA for the three months ending September 30, 2018 was 9.49%.
Baxter ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2018-09-30 $1.21B $16.85B 7.15%
2018-06-30 $0.91B $16.58B 5.36%
2018-03-31 $0.83B $16.89B 4.87%
2017-12-31 $0.72B $17.11B 4.26%
2017-09-30 $1.03B $17.54B 6.28%
2017-06-30 $0.91B $16.96B 5.69%
2017-03-31 $1.86B $15.66B 11.79%
2016-12-31 $4.97B $15.55B 30.71%
2016-09-30 $4.93B $15.80B 28.12%
2016-06-30 $4.80B $15.98B 25.77%
2016-03-31 $3.92B $17.35B 17.71%
2015-12-31 $0.97B $20.96B 4.03%
2015-09-30 $1.72B $20.17B 6.78%
2015-06-30 $2.18B $30.02B 8.19%
2015-03-31 $2.37B $24.86B 9.28%
2014-12-31 $2.50B $26.14B 9.74%
2014-09-30 $1.87B $25.56B 7.36%
2014-06-30 $1.95B $25.63B 7.68%
2014-03-31 $2.02B $25.26B 8.11%
2013-12-31 $2.01B $25.22B 8.51%
2013-09-30 $2.18B $25.25B 9.72%
2013-06-30 $2.22B $23.75B 10.53%
2013-03-31 $2.29B $20.32B 11.60%
2012-12-31 $2.33B $20.39B 12.01%
2012-09-30 $2.30B $19.83B 12.06%
2012-06-30 $2.29B $18.45B 12.34%
2012-03-31 $2.24B $18.78B 12.21%
2011-12-31 $2.22B $19.07B 12.34%
2011-09-30 $2.18B $17.84B 12.39%
2011-06-30 $2.13B $17.74B 12.15%
2011-03-31 $2.05B $17.41B 11.91%
2010-12-31 $1.42B $17.49B 8.27%
2010-09-30 $1.57B $17.56B 9.15%
2010-06-30 $1.57B $16.49B 9.26%
2010-03-31 $1.63B $17.17B 9.68%
2009-12-31 $2.21B $17.35B 13.57%
2009-09-30 $2.20B $16.95B 13.97%
2009-06-30 $2.14B $15.74B 13.99%
2009-03-31 $2.10B $14.95B 13.77%
2008-12-31 $2.01B $15.41B 13.19%
2008-09-30 $1.92B $15.21B 12.62%
2008-06-30 $1.85B $15.47B 12.33%
2008-03-31 $1.73B $14.97B 11.73%
2007-12-31 $1.71B $15.29B 11.66%
2007-09-30 $1.66B $14.15B 11.46%
2007-06-30 $1.64B $14.66B 11.36%
2007-03-31 $1.52B $14.48B 10.82%
2006-12-31 $1.40B $14.69B 10.27%
2006-09-30 $1.26B $13.93B 9.59%
2006-06-30 $1.00B $13.01B 7.64%
2006-03-31 $1.01B $12.78B 7.65%
2005-12-31 $0.96B $12.73B 7.09%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $35.222B $10.561B
Baxter International Inc., through its subsidiaries, develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma and other chronic and acute medical conditions. As a global, diversified healthcare company, Baxter applies a unique combination of expertise in medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide. Baxter India is a wholly owned subsidiary of Baxter International Inc. Baxter India believes in engaging collaboratively with patients, healthcare providers, governments and non - government organizations to help change the lives of millions of people by providing safe, effective and affordable products and therapies.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $128.221B 19.17
Abbott Laboratories (ABT) United States $126.175B 25.57
Stryker (SYK) United States $64.233B 24.21
Boston Scientific (BSX) United States $50.592B 25.57
Zimmer Biomet Holdings (ZBH) United States $22.847B 14.82
Smith & Nephew SNATS (SNN) United Kingdom $16.598B 0.00
ResMed (RMD) United States $16.236B 30.96
Perrigo (PRGO) Ireland $7.946B 12.06
Canopy Growth (CGC) Canada $7.699B 0.00
Bio-Rad Laboratories (BIO) United States $7.552B 48.29
Hill-Rom Holdings (HRC) United States $6.323B 19.78
Aurora Cannabis (ACB) Canada $5.910B 31.21
Haemonetics (HAE) United States $5.336B 46.93
Insulet (PODD) United States $4.873B 0.00
ICU Medical (ICUI) United States $4.821B 26.86
Hutchison China MediTech (HCM) China $4.050B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.710B 0.00
Neogen (NEOG) United States $3.247B 49.17
Agios Pharmaceuticals (AGIO) United States $3.172B 0.00
NuVasive (NUVA) United States $2.911B 27.09
National Vision Holdings (EYE) United States $2.497B 48.30
Quidel (QDEL) United States $2.014B 26.26
NxStage Medical (NXTM) United States $1.931B 0.00
Aphria (APHA) $1.534B 0.00
Phibro Animal Health (PAHC) United States $1.321B 18.70
AtriCure (ATRC) United States $1.182B 0.00
Cardiovascular Systems (CSII) United States $1.013B 1457.00
VAREX IMAGING (VREX) United States $0.925B 18.53
PetIQ (PETQ) United States $0.844B 21.86
Surmodics (SRDX) United States $0.784B 119.47
Meridian Bioscience (VIVO) United States $0.783B 24.96
Cerus (CERS) United States $0.753B 0.00
OraSure Technologies (OSUR) United States $0.733B 41.24
Omeros (OMER) United States $0.709B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.658B 21.10
Lantheus Holdings (LNTH) United States $0.652B 20.18
MacroGenics (MGNX) United States $0.600B 0.00
NanoString Technologies (NSTG) United States $0.534B 0.00
LeMaitre Vascular (LMAT) United States $0.512B 25.14
Owens & Minor (OMI) United States $0.443B 5.01
Quanterix (QTRX) United States $0.429B 0.00
TG Therapeutics (TGTX) United States $0.418B 0.00
Insys Therapeutics (INSY) United States $0.376B 0.00
Evolus (EOLS) United States $0.355B 0.00
Utah Medical Products (UTMD) United States $0.329B 21.25
VAPOTHERM INC (VAPO) United States $0.317B 0.00
Cytosorbents (CTSO) United States $0.278B 0.00
Bovie Medical (BVX) United States $0.240B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.240B 0.00
Surface Oncology (SURF) United States $0.238B 0.00
BioLife Solutions (BLFS) United States $0.213B 288.50
Chimerix (CMRX) United States $0.174B 0.00
Rockwell Medical (RMTI) United States $0.173B 0.00
Imprimis Pharmaceuticals (IMMY) United States $0.139B 0.00
Fonar (FONR) United States $0.132B 6.65
Chembio Diagnostics (CEMI) United States $0.107B 0.00
United-Guardian (UG) United States $0.079B 16.60
Female Health (VERU) United States $0.076B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.070B 0.00
InfuSystems Holdings (INFU) United States $0.066B 0.00
Trinity Biotech (TRIB) Ireland $0.064B 17.87
CAS Medical Systems (CASM) United States $0.055B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.049B 0.00
ImmuCell (ICCC) United States $0.039B 0.00
Neurotrope (NTRP) United States $0.039B 0.00
Myomo (MYO) United States $0.021B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.018B 0.00
Capricor Therapeutics (CAPR) United States $0.017B 0.00
Senestech (SNES) United States $0.016B 0.00
Akers Biosciences Inc (AKER) United States $0.016B 0.00
Cellectar Biosciences (CLRB) United States $0.010B 0.00
Valeritas Holdings (VLRX) United States $0.009B 0.00
NeuroMetrix (NURO) United States $0.008B 0.00